Trials / Completed
CompletedNCT05193071
Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST)
Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST): a Prospective, Random, Double Blinded and Multi-center Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,022 (actual)
- Sponsor
- General Hospital of Shenyang Military Region · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The current guideline recommends to give antithrombotic treatment 24 hours after intravenous thrombolysis in acute ischemic stroke. However, early neurological deterioration will occur in some patients due to no antithrombotic treatment, which is closely associated with poor outcome. The current trial aims to investigate the effectiveness and safety of early antithrombotic treatment after intravenous thrombolysis in minor stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin 100mg; Clopidogrel 300mg | Aspirin 100mg plus Clopidogrel 300mg will be orally administrated after randomization |
Timeline
- Start date
- 2022-07-08
- Primary completion
- 2024-10-25
- Completion
- 2024-10-25
- First posted
- 2022-01-14
- Last updated
- 2024-10-31
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05193071. Inclusion in this directory is not an endorsement.